Item 1. Financial Statements
69K characters. Original on sec.gov · Markdown
Item 1. Financial Statements
TEXTRON INC.
Consolidated Statements of Operations (Unaudited)
| Three Months Ended | ||||||||||||||
| (In millions, except per share amounts) | March 29, 2025 | March 30, 2024 | ||||||||||||
| Revenues | ||||||||||||||
| Manufacturing product revenues | $ | 2,771 | $ | 2,432 | ||||||||||
| Manufacturing service revenues | 519 | 688 | ||||||||||||
| Finance revenues | 16 | 15 | ||||||||||||
| Total revenues | 3,306 | 3,135 | ||||||||||||
| Costs, expenses and other | ||||||||||||||
| Cost of products sold | 2,277 | 1,925 | ||||||||||||
| Cost of services sold | 395 | 545 | ||||||||||||
| Research and development costs | 132 | 144 | ||||||||||||
| Selling and administrative expense | 298 | 316 | ||||||||||||
| Interest expense, net | 29 | 20 | ||||||||||||
| Special charges | — | 14 | ||||||||||||
| Non-service components of pension and postretirement income, net | (66) | (66) | ||||||||||||
| Total costs, expenses and other | 3,065 | 2,898 | ||||||||||||
| Income before income taxes | 241 | 237 | ||||||||||||
| Income tax expense | 34 | 36 | ||||||||||||
| Net income | $ | 207 | $ | 201 | ||||||||||
| Earnings per share | ||||||||||||||
| Basic | $ | 1.14 | $ | 1.04 | ||||||||||
| Diluted | $ | 1.13 | $ | 1.03 |
See Notes to the Consolidated Financial Statements.
TEXTRON INC.
Consolidated Statements of Comprehensive Income (Unaudited)
| Three Months Ended | ||||||||||||||
| (In millions) | March 29, 2025 | March 30, 2024 | ||||||||||||
| Net income | $ | 207 | $ | 201 | ||||||||||
| Other comprehensive income (loss), net of tax | ||||||||||||||
| Pension and postretirement benefits adjustments, net of reclassifications | — | 1 | ||||||||||||
| Foreign currency translation adjustments | 40 | (33) | ||||||||||||
| Deferred losses on hedge contracts, net of reclassifications | (1) | (5) | ||||||||||||
| Other comprehensive income (loss) | 39 | (37) | ||||||||||||
| Comprehensive income | $ | 246 | $ | 164 |
See Notes to the Consolidated Financial Statements.
TEXTRON INC.
Consolidated Balance Sheets (Unaudited)
| (Dollars in millions) | March 29, 2025 | December 28, 2024 | ||||||
| Assets | ||||||||
| Manufacturing group | ||||||||
| Cash and equivalents | $ | 1,194 | $ | 1,386 | ||||
| Accounts receivable, net | 940 | 949 | ||||||
| Inventories | 4,270 | 4,071 | ||||||
| Other current assets | 829 | 687 | ||||||
| Total current assets | 7,233 | 7,093 | ||||||
| Property, plant and equipment, less accumulated depreciation and amortization of $5,564 and $5,471, respectively | 2,503 | 2,529 | ||||||
| Goodwill | 2,297 | 2,288 | ||||||
| Other assets | 4,230 | 4,248 | ||||||
| Total Manufacturing group assets | 16,263 | 16,158 | ||||||
| Finance group | ||||||||
| Cash and equivalents | 51 | 55 | ||||||
| Finance receivables, net | 610 | 603 | ||||||
| Other assets | 18 | 22 | ||||||
| Total Finance group assets | 679 | 680 | ||||||
| Total assets | $ | 16,942 | $ | 16,838 | ||||
| Liabilities and shareholders’ equity | ||||||||
| Liabilities | ||||||||
| Manufacturing group | ||||||||
| Current portion of long-term debt | $ | 356 | $ | 357 | ||||
| Accounts payable | 1,117 | 943 | ||||||
| Other current liabilities | 2,916 | 3,094 | ||||||
| Total current liabilities | 4,389 | 4,394 | ||||||
| Other liabilities | 1,840 | 1,945 | ||||||
| Long-term debt | 3,038 | 2,890 | ||||||
| Total Manufacturing group liabilities | 9,267 | 9,229 | ||||||
| Finance group | ||||||||
| Other liabilities | 60 | 64 | ||||||
| Debt | 340 | 341 | ||||||
| Total Finance group liabilities | 400 | 405 | ||||||
| Total liabilities | 9,667 | 9,634 | ||||||
| Shareholders’ equity | ||||||||
| Common stock | 23 | 23 | ||||||
| Capital surplus | 2,005 | 1,960 | ||||||
| Treasury stock | (299) | (82) | ||||||
| Retained earnings | 5,811 | 5,607 | ||||||
| Accumulated other comprehensive loss | (265) | (304) | ||||||
| Total shareholders’ equity | 7,275 | 7,204 | ||||||
| Total liabilities and shareholders’ equity | $ | 16,942 | $ | 16,838 | ||||
| Common shares outstanding (in thousands) | 180,578 | 182,964 |
See Notes to the Consolidated Financial Statements.
TEXTRON INC.
Consolidated Statements of Cash Flows (Unaudited)
For the Three Months Ended March 29, 2025 and March 30, 2024, respectively
| Consolidated | ||||||||
| (In millions) | 2025 | 2024 | ||||||
| Cash flows from operating activities | ||||||||
| Net income | $ | 207 | $ | 201 | ||||
| Adjustments to reconcile net income to net cash used in operating activities: | ||||||||
| Non-cash items: | ||||||||
| Depreciation and amortization | 92 | 88 | ||||||
| Deferred income taxes | (22) | (16) | ||||||
| Other, net | 41 | 33 | ||||||
| Changes in assets and liabilities: | ||||||||
| Accounts receivable, net | 16 | (34) | ||||||
| Inventories | (183) | (350) | ||||||
| Other assets | (136) | 100 | ||||||
| Accounts payable | 171 | 121 | ||||||
| Other liabilities | (282) | (159) | ||||||
| Income taxes, net | 39 | 39 | ||||||
| Pension, net | (59) | (56) | ||||||
| Captive finance receivables, net | (13) | 22 | ||||||
| Other operating activities, net | 5 | 4 | ||||||
| Net cash used in operating activities | (124) | (7) | ||||||
| Cash flows from investing activities | ||||||||
| Capital expenditures | (56) | (66) | ||||||
| Net proceeds from corporate-owned life insurance policies | 31 | 3 | ||||||
| Proceeds from sale of property, plant and equipment | — | 3 | ||||||
| Finance receivables repaid | 9 | 8 | ||||||
| Finance receivables originated | — | (11) | ||||||
| Other investing activities, net | 15 | — | ||||||
| Net cash used in investing activities | (1) | (63) | ||||||
| Cash flows from financing activities | ||||||||
| Net proceeds from long-term debt | 495 | — | ||||||
| Principal payments on long-term debt and nonrecourse debt | (355) | (365) | ||||||
| Purchases of Textron common stock | (215) | (317) | ||||||
| Proceeds from options exercised | 6 | 63 | ||||||
| Dividends paid | (3) | (4) | ||||||
| Other financing activities, net | (6) | (14) | ||||||
| Net cash used in financing activities | (78) | (637) | ||||||
| Effect of exchange rate changes on cash and equivalents | 7 | (8) | ||||||
| Net decrease in cash and equivalents | (196) | (715) | ||||||
| Cash and equivalents at beginning of period | 1,441 | 2,181 | ||||||
| Cash and equivalents at end of period | $ | 1,245 | $ | 1,466 |
See Notes to the Consolidated Financial Statements.
TEXTRON INC.
Consolidated Statements of Cash Flows (Unaudited) (Continued)
For the Three Months Ended March 29, 2025 and March 30, 2024, respectively
| Manufacturing Group | Finance Group | |||||||||||||
| (In millions) | 2025 | 2024 | 2025 | 2024 | ||||||||||
| Cash flows from operating activities | ||||||||||||||
| Net income | $ | 199 | $ | 187 | $ | 8 | $ | 14 | ||||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||||||||||||||
| Non-cash items: | ||||||||||||||
| Depreciation and amortization | 92 | 88 | — | — | ||||||||||
| Deferred income taxes | (23) | (16) | 1 | — | ||||||||||
| Other, net | 42 | 44 | (1) | (11) | ||||||||||
| Changes in assets and liabilities: | ||||||||||||||
| Accounts receivable, net | 16 | (34) | — | — | ||||||||||
| Inventories | (183) | (350) | — | — | ||||||||||
| Other assets | (136) | 100 | — | — | ||||||||||
| Accounts payable | 171 | 121 | — | — | ||||||||||
| Other liabilities | (276) | (153) | (6) | (6) | ||||||||||
| Income taxes, net | 38 | 35 | 1 | 4 | ||||||||||
| Pension, net | (59) | (56) | — | — | ||||||||||
| Other operating activities, net | 5 | 4 | — | — | ||||||||||
| Net cash provided by (used in) operating activities | (114) | (30) | 3 | 1 | ||||||||||
| Cash flows from investing activities | ||||||||||||||
| Capital expenditures | (56) | (66) | — | — | ||||||||||
| Net proceeds from corporate-owned life insurance policies | 31 | 3 | — | — | ||||||||||
| Proceeds from sale of property, plant and equipment | — | 3 | — | — | ||||||||||
| Finance receivables repaid | — | — | 29 | 47 | ||||||||||
| Finance receivables originated | — | — | (33) | (28) | ||||||||||
| Other investing activities, net | 15 | — | — | — | ||||||||||
| Net cash provided by (used in) investing activities | (10) | (60) | (4) | 19 | ||||||||||
| Cash flows from financing activities | ||||||||||||||
| Net proceeds from long-term debt | 495 | — | — | — | ||||||||||
| Principal payments on long-term debt and nonrecourse debt | (352) | (352) | (3) | (13) | ||||||||||
| Purchases of Textron common stock | (215) | (317) | — | — | ||||||||||
| Proceeds from options exercised | 6 | 63 | — | — | ||||||||||
| Dividends paid | (3) | (4) | — | — | ||||||||||
| Other financing activities, net | (6) | (25) | — | 11 | ||||||||||
| Net cash used in financing activities | (75) | (635) | (3) | (2) | ||||||||||
| Effect of exchange rate changes on cash and equivalents | 7 | (8) | — | — | ||||||||||
| Net increase (decrease) in cash and equivalents | (192) | (733) | (4) | 18 | ||||||||||
| Cash and equivalents at beginning of period | 1,386 | 2,121 | 55 | 60 | ||||||||||
| Cash and equivalents at end of period | $ | 1,194 | $ | 1,388 | $ | 51 | $ | 78 |
See Notes to the Consolidated Financial Statements.
TEXTRON INC.
Notes to the Consolidated Financial Statements (Unaudited)
Note 1. Basis of Presentation
Our Consolidated Financial Statements include the accounts of Textron Inc. (Textron) and its majority-owned subsidiaries. We have prepared these unaudited consolidated financial statements in accordance with accounting principles generally accepted in the U.S. for interim financial information. Accordingly, these interim financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the U.S. for complete financial statements. The consolidated interim financial statements included in this quarterly report should be read in conjunction with the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 28, 2024. In the opinion of management, the interim financial statements reflect all adjustments (consisting only of normal recurring adjustments) that are necessary for the fair presentation of our consolidated financial position, results of operations and cash flows for the interim periods presented. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year.
Our financings are conducted through two separate borrowing groups. The Manufacturing group consists of Textron consolidated with its majority-owned subsidiaries that operate in the Textron Aviation, Bell, Textron Systems, Industrial and Textron eAviation segments. The Finance group, which also is the Finance segment, consists of Textron Financial Corporation and its consolidated subsidiaries. We designed this framework to enhance our borrowing power by separating the Finance group. Our Manufacturing group operations include the development, production and delivery of tangible goods and services, while our Finance group provides financial services. Due to the fundamental differences between each borrowing group’s activities, investors, rating agencies and analysts use different measures to evaluate each group’s performance. To support those evaluations, we present balance sheet and cash flow information for each borrowing group within the Consolidated Financial Statements. All significant intercompany transactions are eliminated from the Consolidated Financial Statements, including retail financing activities for inventory sold by our Manufacturing group and financed by our Finance group.
Use of Estimates
We prepare our financial statements in conformity with generally accepted accounting principles, which require us to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. Our estimates and assumptions are reviewed periodically, and the effects of changes, if any, are reflected in the Consolidated Statements of Operations in the period that they are determined.
Contract Estimates
For contracts where revenue is recognized over time, we recognize changes in estimated contract revenues, costs and profits using the cumulative catch-up method of accounting. This method recognizes the cumulative effect of changes on current and prior periods with the impact of the change from inception-to-date recorded in the current period. Anticipated losses on contracts are recognized in full in the period in which the losses become probable and estimable.
In the first quarter of 2025 and 2024, our cumulative catch-up adjustments increased segment profit by $17 million and $13 million, respectively, and net income by $13 million and $10 million, respectively ($0.07 and $0.05 per diluted share, respectively).
Note 2. Accounts Receivable and Finance Receivables
Accounts Receivable
Accounts receivable is composed of the following:
| (In millions) | March 29, 2025 | December 28, 2024 | ||||||
| Commercial | $ | 792 | $ | 738 | ||||
| U.S. Government contracts | 167 | 230 | ||||||
| 959 | 968 | |||||||
| Allowance for credit losses | (19) | (19) | ||||||
| Total accounts receivable, net | $ | 940 | $ | 949 |
Finance Receivables
Finance receivables are presented in the following table:
| (In millions) | March 29, 2025 | December 28, 2024 | ||||||
| Finance receivables | $ | 629 | $ | 622 | ||||
| Allowance for credit losses | (19) | (19) | ||||||
| Total finance receivables, net | $ | 610 | $ | 603 |
Finance Receivable Portfolio Quality
We internally assess the quality of our finance receivables based on a number of key credit quality indicators and statistics such as delinquency, loan balance to estimated collateral value and the financial strength of individual borrowers and guarantors. Because many of these indicators are difficult to apply across an entire class of receivables, we evaluate individual loans on a quarterly basis and classify these loans into three categories based on the key credit quality indicators for the individual loan. These three categories are performing, watchlist and nonaccrual.
We classify finance receivables as nonaccrual if credit quality indicators suggest full collection of principal and interest is doubtful. In addition, we automatically classify accounts as nonaccrual once they are contractually delinquent by more than three months unless collection of principal and interest is not doubtful. Accounts are classified as watchlist when credit quality indicators have deteriorated as compared with typical underwriting criteria, and we believe collection of full principal and interest is probable but not certain. All other finance receivables that do not meet the watchlist or nonaccrual categories are classified as performing.
We measure delinquency based on the contractual payment terms of our finance receivables. In determining the delinquency aging category of an account, any/all principal and interest received is applied to the most past-due principal and/or interest amounts due. If a significant portion of the contractually due payment is delinquent, the entire finance receivable balance is reported in accordance with the most past-due delinquency aging category.
Finance receivables categorized based on the credit quality indicators and by the delinquency aging category are summarized as follows:
| (Dollars in millions) | March 29, 2025 | December 28, 2024 | ||||||
| Performing | $ | 626 | $ | 612 | ||||
| Nonaccrual | 3 | 10 | ||||||
| Nonaccrual as a percentage of finance receivables | 0.48% | 1.61% | ||||||
| Current and less than 31 days past due | $ | 623 | $ | 609 | ||||
| 31-60 days past due | 6 | 13 | ||||||
| 60+ days contractual delinquency as a percentage of finance receivables | —% | —% |
At March 29, 2025, 40% of our performing finance receivables were originated since the beginning of 2023 and 25% were originated from 2020 to 2022 with the remainder prior to 2020. For finance receivables categorized as nonaccrual, 100% were originated prior to 2020.
On a quarterly basis, we evaluate individual larger balance accounts for impairment. A finance receivable is considered impaired when it is probable that we will be unable to collect all amounts due according to the contractual terms of the loan agreement based on our review of the credit quality indicators described above. Impaired finance receivables include both nonaccrual accounts and accounts for which full collection of principal and interest remains probable, but the account’s original terms have been, or are expected to be, significantly modified. If the modification specifies an interest rate equal to or greater than a market rate for a finance receivable with comparable risk, the account is not considered impaired in years subsequent to the modification. Our impaired finance receivables were insignificant at March 29, 2025 and December 28, 2024.
Note 3. Inventories
Inventories are composed of the following:
| (In millions) | March 29, 2025 | December 28, 2024 | ||||||
| Finished goods | $ | 1,164 | $ | 1,138 | ||||
| Work in process | 1,954 | 1,769 | ||||||
| Raw materials and components | 1,152 | 1,164 | ||||||
| Total inventories | $ | 4,270 | $ | 4,071 |
Note 4. Accounts Payable and Warranty Liability
Accounts Payable
Supplier Financing Arrangement
We have a financing arrangement with one of our suppliers for a maximum amount of $200 million that extends payment terms for up to 190 days from the receipt of goods and provides for the supplier to be paid by a financial institution earlier than maturity. This financing arrangement expires in April 2027. At March 29, 2025 and December 28, 2024, the amount due under the supplier financing arrangement was $91 million and $50 million, respectively.
Warranty Liability
Changes in our current and non-current warranty liability are as follows:
| Three Months Ended | ||||||||
| (In millions) | March 29, 2025 | March 30, 2024 | ||||||
| Beginning of period | $ | 173 | $ | 172 | ||||
| Provision | 17 | 17 | ||||||
| Settlements | (16) | (18) | ||||||
| Adjustments* | (1) | (1) | ||||||
| End of period | $ | 173 | $ | 170 |
** Adjustments include changes to prior year estimates, new issues on prior year sales and currency translation adjustments.*
Note 5. Leases
We primarily lease certain manufacturing plants, offices, warehouses, training and service centers at various locations worldwide that are classified as either operating or finance leases. Our leases have remaining lease terms up to 24 years, which include options to extend the lease term for periods up to 20 years when it is reasonably certain the option will be exercised.
Operating lease cost totaled $18 million in both the first quarter of 2025 and 2024. Cash paid for operating leases approximated the lease cost and is classified in cash flows from operating activities. Noncash transactions related to operating leases totaled $7 million and $25 million in the first quarter of 2025 and 2024, respectively, reflecting new or extended leases. Finance lease, variable and short-term lease costs were not significant.
Balance sheet and other information related to our leases is as follows:
| (Dollars in millions) | March 29, 2025 | December 28, 2024 | ||||||
| Operating leases: | ||||||||
| Other assets | $ | 355 | $ | 360 | ||||
| Other current liabilities | 54 | 55 | ||||||
| Other liabilities | 313 | 316 | ||||||
| Weighted-average remaining lease term (in years) | 9.9 | 10.0 | ||||||
| Weighted-average discount rate | 4.89% | 4.84% | ||||||
| Finance leases: | ||||||||
| Property, plant and equipment, less accumulated amortization of $11 million and $9 million, respectively | $ | 97 | $ | 95 | ||||
| Long-term debt, including current portion | 99 | 97 | ||||||
| Weighted-average remaining lease term (in years) | 6.8 | 5.9 | ||||||
| Weighted-average discount rate | 6.65% | 6.72% |
At March 29, 2025, maturities of our operating lease liabilities on an undiscounted basis totaled $53 million for the remainder of 2025, $59 million for 2026, $49 million for 2027, $46 million for 2028, $41 million for 2029 and $222 million thereafter.
Note 6. Debt
Under our shelf registration statement, on February 13, 2025, we issued $500 million of SEC-registered fixed-rate notes due in May 2035 with an annual interest rate of 5.50%. The net proceeds of the issuance totaled $495 million, after deducting underwriting discounts, commissions and offering expenses.
Note 7. Derivative Instruments and Fair Value Measurements
We measure fair value at the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We prioritize the assumptions that market participants would use in pricing the asset or liability into a three-tier fair value hierarchy. This fair value hierarchy gives the highest priority (Level 1) to quoted prices in active markets for identical assets or liabilities and the lowest priority (Level 3) to unobservable inputs in which little or no market data exist, requiring companies to develop their own assumptions. Observable inputs that do not meet the criteria of Level 1, which include quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets and liabilities in markets that are not active, are categorized as Level 2. Level 3 inputs are those that reflect our estimates about the assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances. Valuation techniques for assets and liabilities measured using Level 3 inputs may include methodologies such as the market approach, the income approach or the cost approach and may use unobservable inputs such as projections, estimates and management’s interpretation of current market data. These unobservable inputs are utilized only to the extent that observable inputs are not available or cost effective to obtain.
Assets and Liabilities Recorded at Fair Value on a Recurring Basis
We manufacture and sell our products in a number of countries throughout the world, and, therefore, we are exposed to movements in foreign currency exchange rates. We primarily utilize foreign currency exchange contracts with maturities of no more than three years to manage this volatility. These contracts qualify as cash flow hedges and are intended to offset the effect of exchange rate fluctuations on forecasted sales, inventory purchases and overhead expenses. Net gains and losses recognized in earnings and Accumulated other comprehensive loss on cash flow hedges, including gains and losses related to hedge ineffectiveness, were not significant in the periods presented.
Our foreign currency exchange contracts are measured at fair value using the market method valuation technique. The inputs to this technique utilize current foreign currency exchange forward market rates published by third-party leading financial news and data providers. These are observable data that represent the rates that the financial institution uses for contracts entered into at that date; however, they are not based on actual transactions, so they are classified as Level 2. At March 29, 2025 and December 28, 2024, we had foreign currency exchange contracts with notional amounts upon which the contracts were based of $683 million and $464 million, respectively. At March 29, 2025, the fair value amounts of our foreign currency exchange contracts were a $6 million asset and a $16 million liability. At December 28, 2024, the fair value amount of our foreign currency exchange contracts were a $5 million asset and a $19 million liability.
Our Finance group enters into interest rate swap agreements to mitigate certain exposures to fluctuations in interest rates. By using these contracts, we are able to convert floating-rate cash flows to fixed-rate cash flows. These agreements are designated as cash flow hedges. The fair value of our interest rate swap agreements is determined using values published by third-party leading financial news and data providers. These values are observable data that represent the value that financial institutions use for contracts entered into at that date, but are not based on actual transactions, so they are classified as Level 2. The fair value of our outstanding interest rate swap agreements was a $4 million and an $8 million asset at March 29, 2025 and December 28, 2024, respectively.
At March 29, 2025 and December 28, 2024, our Finance group had interest rate swap agreements related to our Floating Rate Junior Subordinated Notes for an aggregate notional amount of $264 million that effectively converts the variable-rate interest for these Notes to a weighted-average fixed rate of 5.20%. These agreements have maturities ranging from August 2025 to August 2029. At March 29, 2025 and December 28, 2024, we also had a swap agreement related to these Notes with a notional amount of $30 million and a weighted-average fixed rate of 5.10% that has a forward start date of August 15, 2025 and matures on August 15, 2030.
Assets and Liabilities Not Recorded at Fair Value
The carrying value and estimated fair value of our financial instruments that are not reflected in the financial statements at fair value are as follows:
| March 29, 2025 | December 28, 2024 | |||||||||||||
| Carrying | Estimated | Carrying | Estimated | |||||||||||
| (In millions) | Value | Fair Value | Value | Fair Value | ||||||||||
| Manufacturing group | ||||||||||||||
| Debt, excluding leases | $ | (3,313) | $ | (3,176) | $ | (3,164) | $ | (2,989) | ||||||
| Finance group | ||||||||||||||
| Finance receivables, excluding leases | 452 | 466 | 439 | 454 | ||||||||||
| Debt | (340) | (317) | (341) | (311) |
Fair value for the Manufacturing group debt is determined using market observable data for similar transactions (Level 2). The fair value for the Finance group debt was determined primarily based on discounted cash flow analyses using observable market inputs from debt with similar duration, subordination and credit default expectations (Level 2). Fair value estimates for finance receivables were determined based on internally developed discounted cash flow models primarily utilizing significant unobservable inputs (Level 3), which include estimates of the rate of return, financing cost, capital structure and/or discount rate expectations of current market participants combined with estimated loan cash flows based on credit losses, payment rates and expectations of borrowers’ ability to make payments on a timely basis.
Note 8. Shareholders’ Equity
A reconciliation of Shareholders’ equity is presented below:
| (In millions) | Common Stock | Capital Surplus | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | ||||||||||||||
| Three months ended March 29, 2025 | ||||||||||||||||||||
| Beginning of period | $ | 23 | $ | 1,960 | $ | (82) | $ | 5,607 | $ | (304) | $ | 7,204 | ||||||||
| Net income | — | — | — | 207 | — | 207 | ||||||||||||||
| Other comprehensive income | — | — | — | — | 39 | 39 | ||||||||||||||
| Share-based compensation activity | — | 45 | — | — | — | 45 | ||||||||||||||
| Dividends declared | — | — | — | (3) | — | (3) | ||||||||||||||
| Purchases of common stock, including excise tax* | — | — | (217) | — | — | (217) | ||||||||||||||
| End of period | $ | 23 | $ | 2,005 | $ | (299) | $ | 5,811 | $ | (265) | $ | 7,275 | ||||||||
| Three months ended March 30, 2024 | ||||||||||||||||||||
| Beginning of period | $ | 24 | $ | 1,910 | $ | (165) | $ | 5,862 | $ | (644) | $ | 6,987 | ||||||||
| Net income | — | — | — | 201 | — | 201 | ||||||||||||||
| Other comprehensive loss | — | — | — | — | (37) | (37) | ||||||||||||||
| Share-based compensation activity | 1 | 102 | — | — | — | 103 | ||||||||||||||
| Dividends declared | — | — | — | (4) | — | (4) | ||||||||||||||
| Purchases of common stock, including excise tax* | — | — | (319) | — | — | (319) | ||||||||||||||
| End of period | $ | 25 | $ | 2,012 | $ | (484) | $ | 6,059 | $ | (681) | $ | 6,931 |
*Includes amounts accrued for excise tax imposed on common share repurchases that totaled $2 million for both the first quarter of 2025 and 2024.
Dividends per share of common stock were $0.02 for both the first quarter of 2025 and 2024.
Earnings Per Share
We calculate basic and diluted earnings per share (EPS) based on net income, which approximates income available to common shareholders for each period. Basic EPS is calculated using the two-class method, which includes the weighted-average number of common shares outstanding during the period and restricted stock units to be paid in stock that are deemed participating securities as they provide nonforfeitable rights to dividends. Diluted EPS considers the dilutive effect of all potential future common stock, including stock options.
The weighted-average shares outstanding for basic and diluted EPS are as follows:
| Three Months Ended | ||||||||||||||
| (In thousands) | March 29, 2025 | March 30, 2024 | ||||||||||||
| Basic weighted-average shares outstanding | 182,378 | 192,800 | ||||||||||||
| Dilutive effect of stock options | 1,290 | 2,060 | ||||||||||||
| Diluted weighted-average shares outstanding | 183,668 | 194,860 |
In the first quarter of 2025 and 2024, stock options to purchase 2.1 million and 1.0 million shares, respectively, of common stock were excluded from the calculation of diluted weighted-average shares outstanding as their effect would have been anti-dilutive.
Accumulated Other Comprehensive Loss and Other Comprehensive Income (Loss)
The components of Accumulated other comprehensive loss are presented below:
| (In millions) | Pension and Postretirement Benefits Adjustments | Foreign Currency Translation Adjustments | Deferred Gains (Losses) on Hedge Contracts | Accumulated Other Comprehensive Loss | ||||||||||
| Balance at December 28, 2024 | $ | (179) | $ | (120) | $ | (5) | $ | (304) | ||||||
| Other comprehensive income before reclassifications | — | 40 | (2) | 38 | ||||||||||
| Reclassified from Accumulated other comprehensive loss | — | — | 1 | 1 | ||||||||||
| Balance at March 29, 2025 | $ | (179) | $ | (80) | $ | (6) | $ | (265) | ||||||
| Balance at December 30, 2023 | $ | (598) | $ | (49) | $ | 3 | $ | (644) | ||||||
| Other comprehensive loss before reclassifications | — | (33) | (5) | (38) | ||||||||||
| Reclassified from Accumulated other comprehensive loss | 1 | — | — | 1 | ||||||||||
| Balance at March 30, 2024 | $ | (597) | $ | (82) | $ | (2) | $ | (681) |
The before and after-tax components of Other comprehensive income (loss) are presented below:
| March 29, 2025 | March 30, 2024 | |||||||||||||||||||
| (In millions) | Pre-Tax Amount | Tax (Expense) Benefit | After-tax Amount | Pre-Tax Amount | Tax (Expense) Benefit | After-tax Amount | ||||||||||||||
| Three Months Ended | ||||||||||||||||||||
| Pension and postretirement benefits adjustments: | ||||||||||||||||||||
| Amortization of net actuarial gain* | $ | (2) | $ | — | $ | (2) | $ | (1) | $ | — | $ | (1) | ||||||||
| Amortization of prior service cost* | 2 | — | 2 | 2 | — | 2 | ||||||||||||||
| Pension and postretirement benefits adjustments, net | — | — | — | 1 | — | 1 | ||||||||||||||
| Foreign currency translation adjustments | 40 | — | 40 | (33) | — | (33) | ||||||||||||||
| Deferred losses on hedge contracts: | ||||||||||||||||||||
| Current deferrals | (3) | 1 | (2) | (7) | 2 | (5) | ||||||||||||||
| Reclassification adjustments | 2 | (1) | 1 | (1) | 1 | — | ||||||||||||||
| Deferred losses on hedge contracts, net | (1) | — | (1) | (8) | 3 | (5) | ||||||||||||||
| Total | $ | 39 | $ | — | $ | 39 | $ | (40) | $ | 3 | $ | (37) |
*These components of other comprehensive income (loss) are included in the computation of net periodic pension cost (income). See Note 14 of our 2024 Annual Report on Form 10-K for additional information.
Note 9. Segment Financial Information
We operate in, and report financial information for, the following six operating segments: Textron Aviation, Bell, Textron Systems, Industrial, Textron eAviation and Finance. Segment profit for the manufacturing segments excludes the non-service components of pension and postretirement income, net; LIFO inventory provision; intangible asset amortization; interest expense, net for Manufacturing group; certain corporate expenses; gains/losses on major business dispositions; and special charges. The measurement for the Finance segment includes interest income and expense along with intercompany interest income and expense.
Our revenues and expenses by segment are provided below:
| (In millions) | Textron Aviation | Bell | Textron Systems | Industrial | Textron eAviation | Finance | Total | ||||||||||||||||
| Three months ended March 29, 2025 | |||||||||||||||||||||||
| Revenues | $ | 1,212 | $ | 983 | $ | 296 | $ | 792 | $ | 7 | $ | 16 | $ | 3,306 | |||||||||
| Costs and expenses: | |||||||||||||||||||||||
| Cost of sales | 929 | 803 | 219 | 678 | 6 | — | 2,635 | ||||||||||||||||
| Research and development costs | 57 | 39 | 8 | 14 | 14 | — | 132 | ||||||||||||||||
| Selling and administrative expense | 99 | 51 | 29 | 70 | 4 | 2 | 255 | ||||||||||||||||
| Interest expense, net | — | — | — | — | — | 4 | 4 | ||||||||||||||||
| Segment profit (loss) | $ | 127 | $ | 90 | $ | 40 | $ | 30 | $ | (17) | $ | 10 | $ | 280 | |||||||||
| Three months ended March 30, 2024 | |||||||||||||||||||||||
| Revenues | $ | 1,188 | $ | 727 | $ | 306 | $ | 892 | $ | 7 | $ | 15 | $ | 3,135 | |||||||||
| Costs and expenses: | |||||||||||||||||||||||
| Cost of sales | 891 | 565 | 222 | 758 | 6 | — | 2,442 | ||||||||||||||||
| Research and development costs | 52 | 39 | 18 | 20 | 15 | — | 144 | ||||||||||||||||
| Selling and administrative expense | 102 | 43 | 28 | 85 | 4 | (8) | 254 | ||||||||||||||||
| Interest expense, net | — | — | — | — | — | 5 | 5 | ||||||||||||||||
| Segment profit (loss) | $ | 143 | $ | 80 | $ | 38 | $ | 29 | $ | (18) | $ | 18 | $ | 290 |
A reconciliation of segment profit to income before income taxes, is presented below:
| Three Months Ended | |||||||||||||||||||||||
| (In millions) | March 29, 2025 | March 30, 2024 | |||||||||||||||||||||
| Segment profit | $ | 280 | $ | 290 | |||||||||||||||||||
| Unallocated amounts: | |||||||||||||||||||||||
| Corporate expenses and other, net | (43) | (62) | |||||||||||||||||||||
| Interest expense, net for Manufacturing group | (25) | (15) | |||||||||||||||||||||
| LIFO inventory provision | (29) | (20) | |||||||||||||||||||||
| Intangible asset amortization | (8) | (8) | |||||||||||||||||||||
| Special charges | — | (14) | |||||||||||||||||||||
| Non-service components of pension and postretirement income, net | 66 | 66 | |||||||||||||||||||||
| Income before income taxes | $ | 241 | $ | 237 |
Other information by segment is provided below:
| Capital Expenditures | Depreciation and Amortization | |||||||||||||||||||||||||
| Three Months Ended | Three Months Ended | |||||||||||||||||||||||||
| (In millions) | March 29, 2025 | March 30, 2024 | March 29, 2025 | March 30, 2024 | ||||||||||||||||||||||
| Textron Aviation | $ | 25 | $ | 27 | $ | 37 | $ | 36 | ||||||||||||||||||
| Bell | 15 | 19 | 22 | 19 | ||||||||||||||||||||||
| Textron Systems | 5 | 8 | 12 | 11 | ||||||||||||||||||||||
| Industrial | 10 | 11 | 17 | 18 | ||||||||||||||||||||||
| Textron eAviation | 1 | 1 | 2 | 2 | ||||||||||||||||||||||
| Corporate | — | — | 2 | 2 | ||||||||||||||||||||||
| Total | $ | 56 | $ | 66 | $ | 92 | $ | 88 |
Our assets by segment are summarized below:
| (In millions) | March 29, 2025 | December 28, 2024 | |||||||||||||||||||||
| Textron Aviation | $ | 4,795 | $ | 4,624 | |||||||||||||||||||
| Bell | 3,073 | 2,992 | |||||||||||||||||||||
| Textron Systems | 2,045 | 2,036 | |||||||||||||||||||||
| Industrial | 2,413 | 2,378 | |||||||||||||||||||||
| Textron eAviation | 294 | 286 | |||||||||||||||||||||
| Finance | 679 | 680 | |||||||||||||||||||||
| Corporate | 3,643 | 3,842 | |||||||||||||||||||||
| Total assets | $ | 16,942 | $ | 16,838 |
Note 10. Revenues
Disaggregation of Revenues
Our revenues disaggregated by major product type are presented below:
| Three Months Ended | ||||||||||||||
| (In millions) | March 29, 2025 | March 30, 2024 | ||||||||||||
| Aircraft | $ | 729 | $ | 732 | ||||||||||
| Aftermarket parts and services | 483 | 456 | ||||||||||||
| Textron Aviation | $ | 1,212 | $ | 1,188 | ||||||||||
| Military aircraft and support programs | 634 | 480 | ||||||||||||
| Commercial helicopters, parts and services | 349 | 247 | ||||||||||||
| Bell | $ | 983 | $ | 727 | ||||||||||
| Textron Systems | $ | 296 | $ | 306 | ||||||||||
| Fuel systems and functional components | 450 | 488 | ||||||||||||
| Specialized vehicles | 342 | 404 | ||||||||||||
| Industrial | $ | 792 | $ | 892 | ||||||||||
| Textron eAviation | $ | 7 | $ | 7 | ||||||||||
| Finance | $ | 16 | $ | 15 | ||||||||||
| Total revenues | $ | 3,306 | $ | 3,135 |
Our revenues for our segments by customer type and geographic location are presented below:
| (In millions) | Textron Aviation | Bell | Textron Systems | Industrial | Textron eAviation | Finance | Total | ||||||||||||||||
| Three months ended March 29, 2025 | |||||||||||||||||||||||
| Customer type: | |||||||||||||||||||||||
| Commercial | $ | 1,143 | $ | 361 | $ | 70 | $ | 785 | $ | 7 | $ | 16 | $ | 2,382 | |||||||||
| U.S. Government | 69 | 622 | 226 | 7 | — | — | 924 | ||||||||||||||||
| Total revenues | $ | 1,212 | $ | 983 | $ | 296 | $ | 792 | $ | 7 | $ | 16 | $ | 3,306 | |||||||||
| Geographic location: | |||||||||||||||||||||||
| United States | $ | 912 | $ | 682 | $ | 269 | $ | 408 | $ | 3 | $ | 4 | $ | 2,278 | |||||||||
| Europe | 86 | 56 | 12 | 164 | 3 | — | 321 | ||||||||||||||||
| Other international | 214 | 245 | 15 | 220 | 1 | 12 | 707 | ||||||||||||||||
| Total revenues | $ | 1,212 | $ | 983 | $ | 296 | $ | 792 | $ | 7 | $ | 16 | $ | 3,306 | |||||||||
| Three months ended March 30, 2024 | |||||||||||||||||||||||
| Customer type: | |||||||||||||||||||||||
| Commercial | $ | 1,155 | $ | 239 | $ | 72 | $ | 884 | $ | 7 | $ | 15 | $ | 2,372 | |||||||||
| U.S. Government | 33 | 488 | 234 | 8 | — | — | 763 | ||||||||||||||||
| Total revenues | $ | 1,188 | $ | 727 | $ | 306 | $ | 892 | $ | 7 | $ | 15 | $ | 3,135 | |||||||||
| Geographic location: | |||||||||||||||||||||||
| United States | $ | 950 | $ | 559 | $ | 274 | $ | 460 | $ | 4 | $ | 4 | $ | 2,251 | |||||||||
| Europe | 62 | 23 | 13 | 198 | 2 | 5 | 303 | ||||||||||||||||
| Other international | 176 | 145 | 19 | 234 | 1 | 6 | 581 | ||||||||||||||||
| Total revenues | $ | 1,188 | $ | 727 | $ | 306 | $ | 892 | $ | 7 | $ | 15 | $ | 3,135 |
Remaining Performance Obligations
Our remaining performance obligations, which is the equivalent of our backlog, represent the expected transaction price allocated to our contracts that we expect to recognize as revenues in future periods when we perform under the contracts. These remaining obligations exclude unexercised contract options and potential orders under ordering-type contracts such as Indefinite Delivery, Indefinite Quantity contracts. At March 29, 2025, we had $17.2 billion in remaining performance obligations of which we expect to recognize revenues of approximately 78% through 2026, an additional 18% through 2028, and the balance thereafter.
Contract Assets and Liabilities
Assets and liabilities related to our contracts with customers are reported on a contract-by-contract basis at the end of each reporting period. At March 29, 2025 and December 28, 2024, contract assets totaled $478 million and $345 million, respectively, and contract liabilities totaled $1.9 billion at both dates, reflecting timing differences between revenues recognized, billings and payments from customers. We recognized revenues of $340 million and $327 million in the first quarter of 2025 and 2024, respectively, that were included in the contract liability balance at the beginning of each year.
Note 11. Share-Based Compensation
Under our share-based compensation plan, we have authorization to provide awards to selected employees and non-employee directors in the form of stock options, restricted stock, restricted stock units, stock appreciation rights, performance stock, performance share units and other awards. Compensation expense included in net income for our share-based compensation plans is as follows:
| Three Months Ended | ||||||||
| (In millions) | March 29, 2025 | March 30, 2024 | ||||||
| Compensation expense | $ | 34 | $ | 77 | ||||
| Income tax benefit | (8) | (19) | ||||||
| Total compensation expense included in net income | $ | 26 | $ | 58 |
Compensation expense included stock option expense of $13 million and $15 million in the first quarter of 2025 and 2024, respectively. We typically grant stock appreciation rights to selected non-U.S. employees. At March 29, 2025, outstanding stock appreciation rights totaled 446,753 with a weighted-average exercise price of $66.21 and a weighted-average remaining contractual life of 6.6 years; these units had an intrinsic value of $4 million, compared with $14 million at March 30, 2024.
Stock Options
Options to purchase our shares have a maximum term of ten years and generally vest ratably over a three-year period. Stock option compensation cost is calculated under the fair value approach using the Black-Scholes option-pricing model to determine the fair value of options granted on the date of grant. The expected volatility used in this model is based on historical volatilities and implied volatilities from traded options on our common stock. The expected term is based on historical option exercise data, which is adjusted to reflect any anticipated changes in expected behavior.
We grant options annually on the first day of March. The assumptions used in our option-pricing model for these grants and the weighted-average fair value for these options are as follows:
| March 1, 2025 | March 1, 2024 | |||||||
| Fair value of options at grant date | $ | 22.01 | $ | 27.69 | ||||
| Dividend yield | 0.1% | 0.1% | ||||||
| Expected volatility | 25.1% | 27.2% | ||||||
| Risk-free interest rate | 4.1% | 4.3% | ||||||
| Expected term (in years) | 4.8 | 4.8 |
The stock option activity during the first quarter of 2025 is provided below:
| (Options in thousands) | Number of Options | Weighted- Average Exercise Price | ||||||
| Outstanding at December 28, 2024 | 6,649 | $ | 61.70 | |||||
| Granted | 995 | 74.73 | ||||||
| Exercised | (158) | (46.73) | ||||||
| Forfeited or expired | (21) | (79.48) | ||||||
| Outstanding at March 29, 2025 | 7,465 | $ | 63.71 | |||||
| Exercisable at March 29, 2025 | 5,354 | $ | 57.77 |
At March 29, 2025, our outstanding options had an aggregate intrinsic value of $87 million and a weighted-average remaining contractual life of 6.0 years. Our exercisable options had an aggregate intrinsic value of $87 million and a weighted-average remaining contractual life of 4.8 years at March 29, 2025. The total intrinsic value of options exercised during the first quarter of 2025 and 2024 was $4 million and $60 million, respectively.
Restricted Stock Units
We issue restricted stock units that include the right to receive dividend equivalents and are settled in either cash or stock. Grants of restricted stock units vest in full on the third anniversary of the grant date. Compensation cost is determined using the fair value of these units based on the trading price of our common stock. For units payable in stock, we use the trading price on the grant date, while units payable in cash are remeasured using the price at each reporting period date.
The activity for restricted stock units during the first quarter of 2025 is provided below:
| Units Payable in Stock | Units Payable in Cash | ||||||||||||||||
| (Shares/Units in thousands) | Number of Shares | Weighted- Average Grant Date Fair Value | Number of Units | Weighted- Average Grant Date Fair Value | |||||||||||||
| Outstanding at December 28, 2024, nonvested | 331 | $ | 75.50 | 631 | $ | 77.75 | |||||||||||
| Granted | 96 | 74.73 | 244 | 74.87 | |||||||||||||
| Vested | (81) | (71.07) | (192) | (71.07) | |||||||||||||
| Forfeited | — | — | (8) | (77.79) | |||||||||||||
| Outstanding at March 29, 2025, nonvested | 346 | $ | 76.32 | 675 | $ | 78.61 |
The fair value of the restricted stock unit awards that vested and/or amounts paid under these awards is as follows:
| Three Months Ended | ||||||||
| (In millions) | March 29, 2025 | March 30, 2024 | ||||||
| Fair value of awards vested | $ | 20 | $ | 41 | ||||
| Cash paid | 14 | 33 |
Performance Share Units
The activity for our performance share units during the first quarter of 2025 is as follows:
| (Units in thousands) | Number of Units | Weighted- Average Grant Date Fair Value | ||||||
| Outstanding at December 28, 2024, nonvested | 394 | $ | 80.81 | |||||
| Granted | 199 | 74.73 | ||||||
| Outstanding at March 29, 2025, nonvested | 593 | $ | 78.77 |
Cash paid under these awards totaled $16 million and $35 million in the first quarter of 2025 and 2024, respectively.
Note 12. Retirement Plans
We provide defined benefit pension plans and other postretirement benefits to eligible employees. The components of net periodic benefit (income) cost for these plans are as follows:
| Three Months Ended | ||||||||||||||
| (In millions) | March 29, 2025 | March 30, 2024 | ||||||||||||
| Pension Benefits | ||||||||||||||
| Service cost | $ | 16 | $ | 17 | ||||||||||
| Interest cost | 94 | 90 | ||||||||||||
| Expected return on plan assets | (162) | (159) | ||||||||||||
| Amortization of net actuarial loss | — | 1 | ||||||||||||
| Amortization of prior service cost | 2 | 2 | ||||||||||||
| Net periodic benefit income* | $ | (50) | $ | (49) | ||||||||||
| Postretirement Benefits Other Than Pensions | ||||||||||||||
| Interest cost | $ | 2 | $ | 2 | ||||||||||
| Amortization of net actuarial gain | (2) | (2) | ||||||||||||
| Net periodic benefit (income) cost | $ | — | $ | — |
** Excludes the cost associated with the defined contribution component, included in certain of our U.S.-based defined benefit pension plans, that totaled $3 million and $4 million for the first quarter of 2025 and 2024, respectively.*
Note 13. Special Charges
In the first quarter of 2024, we recognized special charges of $14 million related to a 2023 restructuring plan. There were no special charges recorded in the first quarter of 2025.
Our restructuring reserve activity is summarized below:
| (In millions) | Severance Costs | Contract Terminations and Other | Total | ||||||||
| Balance at December 28, 2024 | $ | 37 | $ | 34 | $ | 71 | |||||
| Cash paid | (7) | (12) | (19) | ||||||||
| Foreign currency translation | 1 | — | 1 | ||||||||
| Balance at March 29, 2025 | $ | 31 | $ | 22 | $ | 53 |
Note 14. Income Taxes
Our effective tax rate for the first quarter of 2025 and 2024 was 14.1% and 15.2%, respectively. In the first quarter of 2025, the effective tax rate was lower than the U.S. federal statutory rate of 21%, largely due to the favorable impact of research and development credits and tax deductions for foreign-derived intangible income. In the first quarter of 2024, the effective tax rate was lower than the U.S. federal statutory rate of 21%, largely due to the recognition of excess tax benefits related to share-based compensation, the favorable impact of research and development credits, and tax deductions for foreign-derived intangible income.
Note 15. Commitments and Contingencies
We are subject to actual and threatened legal proceedings and other claims arising out of the conduct of our business, including proceedings and claims relating to commercial and financial transactions; government contracts; alleged lack of compliance with applicable laws and regulations; disputes with suppliers, production partners or other third parties; product liability; patent and trademark infringement; employment disputes; and environmental, health and safety matters. Some of these legal proceedings and claims seek damages, fines or penalties in substantial amounts or remediation of environmental contamination. As a government contractor, we are subject to audits, reviews and investigations to determine whether our operations are being conducted in accordance with applicable regulatory requirements. Under federal government procurement regulations, certain claims brought by the U.S. Government could result in our suspension or debarment from U.S. Government contracting for a period of time. On the basis of information presently available, we do not believe that existing proceedings and claims will have a material effect on our financial position or results of operations.
Note 16. Subsequent Event
Within the Industrial segment, we have completed the previously announced strategic review of the Powersports product line. On April 23, 2025, we closed on the sale of the Powersports business, including the Arctic Cat brand and its operations. The proceeds and estimated after-tax gain on this transaction will be reported in the second quarter of 2025 and are not expected to be material.
Previous: Cover and table of contents · Next: Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations